Matt Toresco, Author at Archo

Why Pharma Needs to Rethink Advocacy Budgets and Teams

December 8, 2024
Matt Toresco
No Comments

I would say there are two key “ahas” that come out of the BIOADVOCATE BENCHMARK. The first is that the industry is only spending between 0.01% and 0.08% of annual revenue on advocacy. In my opinion, that’s laughable—it’s way too small. But with that has also come some realization. To…

01 Dec 24

Amplify Your Advocacy Voice – Introducing “Bridging the Gap” White Paper

Amplify Your Advocacy Voice – Introducing “Bridging the Gap” White Paper Table of Contents In the evolving landscape of patient advocacy, professionals often find themselves navigating complex systems with constrained resources, limited internal support, and regulatory hurdles. What if there was a resource that could articulate the challenges you face…

18 Nov 24

Copy of From Data to Impact: Turning Insights Into Meaningful Change

Table of Contents In healthcare today, there’s an intense focus on the potential of AI, digital health tools, and vast datasets to transform patient care. But as we dive into these technologies, we must ask ourselves: How can we ensure that the tools, resources & insights we have at our…

06 Nov 24

Integrating AI in Healthcare Without Losing Sight of the Patient Voice

Table of Contents Integrating AI in Healthcare Without Losing Sight of the Patient Voice As artificial intelligence (AI) rapidly integrates into healthcare, it promises to revolutionize the industry by streamlining workflows, reducing administrative burdens, and improving patient outcomes. Yet, while AI holds the potential to enhance healthcare delivery, it’s…

21 Oct 24

The 2024 Declaration of Helsinki: A New Era of Patient-Centric Research

The 2024 Declaration of Helsinki: A New Era of Patient-Centric Research For over half a century, the Declaration of Helsinki has served as the global benchmark for ethical standards in medical research involving human subjects. First adopted in 1964 by the World Medical Association, its core mission has remained unchanged:…

19 Feb 24

Embracing a New Era in Clinical Trials: Learning from the Past for a More Inclusive Future

The journey towards equitable clinical trials in healthcare requires confronting and learning from past transgressions. For those leading patient advocacy in the biotech and pharmaceutical sectors, recognizing these historical challenges is vital to fostering trust and diversity in research. Henrietta Lacks’ story, where her cells were used without consent, and…

19 Feb 24

The Need for Change in the FDA Approval Process: Rebuilding Trust and Ensuring Patient-Centric Approvals

Table of Contents Introduction The Food and Drug Administration (FDA) plays a crucial role in regulating drugs and medical products in the United States. As a central body that approves or disapproves drugs, the FDA holds a significant amount of responsibility for maintaining the safety and efficacy of medical treatments.…